Literature DB >> 29743859

Recent updates on neuropharmacological effects of luteolin.

Gaurav Gupta1, Juhi Tiwari1, Rajiv Dahiya2, Rakesh Kumar Sharma3, Anurag Mishra3, Kamal Dua4,5.   

Abstract

Entities:  

Year:  2018        PMID: 29743859      PMCID: PMC5938528          DOI: 10.17179/excli2018-1041

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Dear Editor, Luteolin (3,4,5,7-tetrahydroxyflavone) is a naturally found flavone, which is obtained from numerous plant species (Kim and Kim, 2012[5]). Chemically, it has a C6-C3-C6 structure that contains two benzene rings and one oxygen-containing ring with a C2-C3 carbon double bond. Structure-activity studies (SAS) have revealed that the presence of hydroxyl moieties at carbons 5, 7, 3 and 4 positions of the luteolin structure and the presence of the 2-3 double bond are accountable for its numerous pharmacological activities (Lin et al., 2008[8]). Luteolin is naturally found as a glycosylated form, is existing in several types of fruits and vegetables, such as pepper, thyme, broccoli, and celery (Lopez-Lazaro, 2009[10]). Various research studies have confirmed that luteolin possesses antioxidant, anticancer, anti-inflammatory, and neuroprotective effects; though, a coherent review of the scientific literature related to its neuroprotective effects is still lacking. In this letter, conclusive evidences have been presented for the potent antioxidant activity of luteolin reported in various in vitro and in vivo studies (Table 1(Tab. 1); References in Table 1: Wang et al., 2017[19]; Kim et al., 2017[6]; Zhang et al., 2017[25]; Tambe et al., 2017[16]; Shen et al., 2016[15]; Wang et al., 2016[18]; Zhen et al., 2016[26]; Burton et al., 2016[2]; Yu et al., 2015[24]; Lamy et al., 2015[7]; Fu et al., 2014[4]; Bandaruk et al., 2014[1]; Xu et al., 2014[20]; Patil et al., 2014[12]; Zhu et al., 2014[27]; Yan et al., 2014[22]; Wang et al., 2015[17]; Xu et al., 2014[21]; Nazari et al., 2013[11]; Yoo et al., 2013[23]; Liu et al., 2013[9]; Qiao et al., 2012[13]; Qiao et al., 2012[14]). Luteolin also reduces inflammation in brain tissues and in regulating different cell signaling pathways (Dirscherl et al., 2010[3]). Oxidative stress and neuro-inflammation are possible drivers of neurodegeneration. Thus, a chemical moiety like luteolin with potential antioxidant and anti-inflammatory activity could be used as a therapeutic agent for neurodegenerative diseases.
Table 1

Recent updates on neuropharmacological effects of luteolin

Conflict of interest

The authors declare no conflict of interest.
  26 in total

1.  Effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia model.

Authors:  Dae Young Yoo; Jung Hoon Choi; Woosuk Kim; Sung Min Nam; Hyo Young Jung; Jong Hwi Kim; Moo-Ho Won; Yeo Sung Yoon; In Koo Hwang
Journal:  Neurol Res       Date:  2013-05-03       Impact factor: 2.448

2.  Biphasic effects of luteolin on interleukin-1β-induced cyclooxygenase-2 expression in glioblastoma cells.

Authors:  Sylvie Lamy; Paula Liana Moldovan; Aroua Ben Saad; Borhane Annabi
Journal:  Biochim Biophys Acta       Date:  2014-10-18

3.  Luteolin rescues pentylenetetrazole-induced cognitive impairment in epileptic rats by reducing oxidative stress and activating PKA/CREB/BDNF signaling.

Authors:  Jun-Li Zhen; Ying-Na Chang; Zhen-Zhen Qu; Tao Fu; Jian-Qun Liu; Wei-Ping Wang
Journal:  Epilepsy Behav       Date:  2016-03-08       Impact factor: 2.937

4.  Protective effect of luteolin on an oxidative-stress model induced by microinjection of sodium nitroprusside in mice.

Authors:  Qand Agha Nazari; Toshiaki Kume; Yuki Takada-Takatori; Yasuhiko Izumi; Akinori Akaike
Journal:  J Pharmacol Sci       Date:  2013-05-24       Impact factor: 3.337

5.  Protective effects of luteolin against cognitive impairment induced by infusion of Aβ peptide in rats.

Authors:  Tian-Xia Yu; Peng Zhang; Yan Guan; Min Wang; Ming-Qing Zhen
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice.

Authors:  Sachin P Patil; Pankaj D Jain; Jayant S Sancheti; Priya J Ghumatkar; Rufi Tambe; Sadhana Sathaye
Journal:  Neuropharmacology       Date:  2014-07-31       Impact factor: 5.250

7.  Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells.

Authors:  Lihong Zhu; Wei Bi; Dan Lu; Chanjuan Zhang; Xiaoming Shu; Daxiang Lu
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

8.  Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model.

Authors:  Huimin Wang; Huiling Wang; Huixin Cheng; Zhenyong Che
Journal:  Mol Med Rep       Date:  2016-03-28       Impact factor: 2.952

9.  Luteolin inhibits GABAA receptors in HEK cells and brain slices.

Authors:  Mei-Lin Shen; Chen-Hung Wang; Rita Yu-Tzu Chen; Ning Zhou; Shung-Te Kao; Dong Chuan Wu
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

10.  Cellular uptake of quercetin and luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells.

Authors:  Yauhen Bandaruk; Rie Mukai; Junji Terao
Journal:  Toxicol Rep       Date:  2014-09-06
View more
  1 in total

Review 1.  Plants as a Source of Anticancer Agents: From Bench to Bedside.

Authors:  Wamidh H Talib; Safa Daoud; Asma Ismail Mahmod; Reem Ali Hamed; Dima Awajan; Sara Feras Abuarab; Lena Hisham Odeh; Samar Khater; Lina T Al Kury
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.